AU2001289102A1 - Topical formulations for delivery of interleukin-11 - Google Patents

Topical formulations for delivery of interleukin-11

Info

Publication number
AU2001289102A1
AU2001289102A1 AU2001289102A AU8910201A AU2001289102A1 AU 2001289102 A1 AU2001289102 A1 AU 2001289102A1 AU 2001289102 A AU2001289102 A AU 2001289102A AU 8910201 A AU8910201 A AU 8910201A AU 2001289102 A1 AU2001289102 A1 AU 2001289102A1
Authority
AU
Australia
Prior art keywords
interleukin
delivery
topical formulations
topical
formulations
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001289102A
Inventor
Camille L. Bedrosian
James C. Keith Jr.
Paul F. Schendel
Ullrich S. Schwerschlag
Nicholas W Warne
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Genetics Institute LLC
Original Assignee
Genetics Institute LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genetics Institute LLC filed Critical Genetics Institute LLC
Publication of AU2001289102A1 publication Critical patent/AU2001289102A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/20—Interleukins [IL]
    • A61K38/2073—IL-11
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
AU2001289102A 2000-09-15 2001-09-17 Topical formulations for delivery of interleukin-11 Abandoned AU2001289102A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US09/662,994 US6540993B1 (en) 1995-06-27 2000-09-15 Method of treating inflammatory bowel disease using a topical formulation of IL-11
US09/662,994 2000-09-15
PCT/US2001/028886 WO2002022156A2 (en) 2000-09-15 2001-09-17 Topical formulations for delivery of interleukin-11

Publications (1)

Publication Number Publication Date
AU2001289102A1 true AU2001289102A1 (en) 2002-03-26

Family

ID=24660067

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001289102A Abandoned AU2001289102A1 (en) 2000-09-15 2001-09-17 Topical formulations for delivery of interleukin-11

Country Status (6)

Country Link
US (2) US6540993B1 (en)
EP (1) EP1320358A2 (en)
AR (1) AR031610A1 (en)
AU (1) AU2001289102A1 (en)
TW (1) TWI241192B (en)
WO (1) WO2002022156A2 (en)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6540993B1 (en) * 1995-06-27 2003-04-01 Wyeth Method of treating inflammatory bowel disease using a topical formulation of IL-11
JP2005508836A (en) * 2001-03-15 2005-04-07 エンテロン ファーマシューティカルズ インコーポレーティッド Method for treating inflammatory diseases of the gastrointestinal tract using locally acting corticosteroids
WO2003049693A2 (en) * 2001-12-06 2003-06-19 Wyeth Method and composition for inducing weight loss
US20030194421A1 (en) * 2001-12-28 2003-10-16 Angiotech Pharmaceuticals, Inc. Treatment of uveitis
US6982080B2 (en) * 2002-03-15 2006-01-03 Wyeth Hydroxyethyl starch—containing polypeptide compositions
CN1688293A (en) * 2002-09-16 2005-10-26 韦思公司 Delayed release formulations for oral administration of a polypeptide therapeutic agent and methods of using same
US8034048B2 (en) * 2003-05-05 2011-10-11 Boston Scientific Scimed, Inc. Tissue patches and related delivery systems and methods
US7416546B2 (en) * 2003-05-05 2008-08-26 Boston Scientific Scimed, Inc. Tissue patches and related delivery systems and methods
EP1704164B1 (en) * 2003-12-03 2011-12-28 Kröz, Monika Interleukin-11 fusion proteins
US20080069796A1 (en) * 2006-07-31 2008-03-20 Kim Jong-Mook Low Dose Treatment with an Interleukin-11 Analog
WO2008050789A1 (en) * 2006-10-27 2008-05-02 The New Industry Research Organization Use of interleukin-11 as therapeutic agent for heart disease
US9125807B2 (en) * 2007-07-09 2015-09-08 Incept Llc Adhesive hydrogels for ophthalmic drug delivery
US8182814B2 (en) * 2007-10-26 2012-05-22 Csl Limited Methods of treating inflammatory airway conditions by inhibition of IL-11 activity
EP2396070A4 (en) 2009-02-12 2012-09-19 Incept Llc Drug delivery through hydrogel plugs
US10413506B2 (en) 2010-04-03 2019-09-17 Praful Doshi Medical devices including medicaments and methods of making and using same including enhancing comfort, enhancing drug penetration, and treatment of myopia
WO2011123180A1 (en) 2010-04-03 2011-10-06 Praful Doshi Medical devices including medicaments and methods of making and using same
US8961501B2 (en) 2010-09-17 2015-02-24 Incept, Llc Method for applying flowable hydrogels to a cornea
US10226417B2 (en) 2011-09-16 2019-03-12 Peter Jarrett Drug delivery systems and applications
US9636381B2 (en) 2012-01-18 2017-05-02 Neumedicines, Inc. Methods for radiation protection by administering IL-12
GB201522186D0 (en) 2015-12-16 2016-01-27 Singapore Health Services Pte Ltd And Nat University Of Singapore The Treatment of fibrosis
GB201621439D0 (en) 2016-12-16 2017-02-01 Singapore Health Services Pte Ltd And Nat Univ Of Singapore IL-11Ra Antibodies
WO2018109174A2 (en) 2016-12-16 2018-06-21 Singapore Health Services Pte Ltd Il-11 antibodies
EP3914621A1 (en) 2019-01-21 2021-12-01 Singapore Health Services Pte. Ltd. Treatment of hepatotoxicity

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0082481B2 (en) 1981-12-23 1990-09-12 Schering Corporation Stabilised alpha-interferon formulations and their preparation
EP0158487B1 (en) 1984-04-09 1991-08-28 Takeda Chemical Industries, Ltd. Stable composition of interleukin-2
JPS60243028A (en) 1984-04-28 1985-12-03 Kyowa Hakko Kogyo Co Ltd Solubilization of interferon
US5236704A (en) 1988-01-28 1993-08-17 Sumitomo Pharmaceuticals Co., Ltd. Controlled release formulation
US5215743A (en) 1988-04-13 1993-06-01 Maninder Singh Tumor necrosis factor formulations
US5215895A (en) 1989-11-22 1993-06-01 Genetics Institute, Inc. Dna encoding a mammalian cytokine, interleukin-11
US5371193A (en) 1990-05-21 1994-12-06 Genetics Institute, Inc. - Legal Affairs Mammalian cytokine, IL-11
ES2118756T5 (en) 1990-08-29 2004-01-16 Genetics Institute, Llc HEMATOPOYESIS STIMULATORS OF MULTIPLE DOMAINS.
US5270181A (en) 1991-02-06 1993-12-14 Genetics Institute, Inc. Peptide and protein fusions to thioredoxin and thioredoxin-like molecules
US5292646A (en) 1991-02-06 1994-03-08 Genetics Institute, Inc. Peptide and protein fusions to thioredoxin and thioredoxin-like molecules
KR100225153B1 (en) 1991-04-08 1999-10-15 다께우찌 마사야쓰 Porous solid preparation containing physiologically active protein substance
US5472711A (en) 1992-07-30 1995-12-05 Edward Mendell Co., Inc. Agglomerated hydrophilic complexes with multi-phasic release characteristics
US5460810A (en) 1992-09-02 1995-10-24 Genetics Institute, Inc. Method for maintaining gut epithelial cells by treatment with a cytokine such as interleukin 11
US5358708A (en) 1993-01-29 1994-10-25 Schering Corporation Stabilization of protein formulations
US5455046A (en) 1993-09-09 1995-10-03 Edward Mendell Co., Inc. Sustained release heterodisperse hydrogel systems for insoluble drugs
US5543138A (en) 1994-03-10 1996-08-06 Genetics Institute, Inc. Methods of diagnosing and treating preeclampsia
DE69422161T3 (en) * 1994-05-27 2004-06-03 Agrano Ag Process for obtaining a biomass and bread blowing agent
US5612053A (en) 1995-04-07 1997-03-18 Edward Mendell Co., Inc. Controlled release insufflation carrier for medicaments
US5679339A (en) 1995-06-27 1997-10-21 Keith; James Method of using IL-11 for treating spondyloarthropies
US6540993B1 (en) * 1995-06-27 2003-04-01 Wyeth Method of treating inflammatory bowel disease using a topical formulation of IL-11
US6126933A (en) * 1995-06-27 2000-10-03 Genetics Institute Methods of treating inflammatory bowel diseases by administering IL-11
CA2379354A1 (en) 1999-07-15 2001-01-25 Genetics Institute, Inc. Formulations for il-115

Also Published As

Publication number Publication date
US20030147849A1 (en) 2003-08-07
WO2002022156A3 (en) 2002-06-13
EP1320358A2 (en) 2003-06-25
US6540993B1 (en) 2003-04-01
AR031610A1 (en) 2003-09-24
TWI241192B (en) 2005-10-11
WO2002022156A8 (en) 2003-02-20
WO2002022156A2 (en) 2002-03-21

Similar Documents

Publication Publication Date Title
AU2001289102A1 (en) Topical formulations for delivery of interleukin-11
AU781269C (en) Pharmaceutical compositions
AU6310000A (en) Aerosol formulations
AU2002222118A1 (en) Pharmaceutical compositions for inhalation
GC0000397A (en) Olopatadine formulations for topical administration
AU2001257326A1 (en) Topical anesthetic/opioid formulations and uses thereof
AU2002333644A1 (en) Dry powder medicament formulations
AU2002239397A1 (en) Drug formulation having improved oral tolerability
AU2002330273A1 (en) Liposome-encapsulated insulin formulations
AU2001250420A1 (en) Pharmaceutical compositions
AU2001231000A1 (en) Dry powder formulations of antihistamine for nasal administration
AU2001274307A1 (en) Pharmaceutical compositions
AU3192700A (en) Medicinal compositions
AU2001292185A1 (en) Formulation containing amoxicillin
AUPQ441699A0 (en) Pour-on formulations
AU2001266338A1 (en) Pharmaceutical compositions for angiogenic therapy
AU5286901A (en) Topical anesthetic formulation
AU2005300A (en) Medicinal compositions
AU2001267707A1 (en) Antiperspirant formulations
AU4328800A (en) Pharmaceutical formulation
AU2002214324A1 (en) Medicinal compositions
AU2001284444A1 (en) Preparations for oral administration
AU4905499A (en) Topical aciclovir formulations
AU6715600A (en) Pharmaceutical formulations
AU2001234089A1 (en) Cancer remedy comprising anthranilic acid derivative as active ingredient